India: Prices of 869 Formulations to Go up by Over 3%
Prices of 869 formulations, including antibiotics, cancer and cardiovascular disease treatment drugs and two types of coronary stents, have gone up by 3.44%, according to the National Pharmaceutical Pricing Authority (NPPA).
The NPPA is mandated to fix/revise the prices of controlled bulk drugs and formulations and to enforce prices and availability of the medicines in the country. It also monitors the prices of decontrolled drugs in order to keep them at reasonable levels.
2026-08-15
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
in-cosmetics Global reveals line-up for 2026 programme curated for innovation
-
Agri Technology Asia(2024) will be held in Lahore from July 27-29
-
Prospects for plant protection mergers and acquisitions in Central America and Mexico
-
Bayer Australia is officially certified and 60 products are produced locally
-
The 24th ACE will be held in Shanghai in November
-
An important layout in the overseas market, Zhongxun (Thailand)Agri-Science officially opened
-
The bird repellent market has great growth potential and is expected to reach $420 million by 2028
-
Huaxing’s Spinosad formulation products obtained U.S. OMRI certification
-
In the past 5 years, 102 pesticide products have been registered for cotton in China, with more PGR
-
The annual output of 5,000 tons of Penoxsulam and Glufosinate-ammonium project’s environmental assessment was published
Recommend Reading
-
Rising Naphtha Prices in Japan Drive Up Costs for Diapers, Sanitary Products, and Cosmetics
-
Global Chemical Inventories Hit Critical Lows as Over 200 Chinese Companies Suspend Quotations
-
Do You Know the Food Zero Additives?
-
Chemicals Are Going Wild: Sulfur Surges 512%, Titanium Dioxide, Polyols and Sulfuric Acid Lose Control
-
Hengli Sanctions Spill Over: One Barrel of Iranian Crude Pulls an Aromatics Chain Into Risk
-
DMF Supply Tightens in Early April, Prices Remain Strong
-
Sell Signal Alert! Melamine Drops Sharply to "Low Position" in 10 Days, Short-term Momentum Weakens
-
Demand Sluggish, TDI Market Stalls at High Levels
-
Weak Demand, Downward Trend in Butadiene Market
-
In the first half of April, China's titanium dioxide market prices increased